InspireMD (NSPR) EBIT Growth (5y) (2015 - 2025)
InspireMD (NSPR) EBIT Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -26.58% |
| Sep 30, 2025 | -42.84% |
| Jun 30, 2025 | -39.71% |
| Mar 31, 2025 | -41.49% |
| Dec 31, 2024 | -30.17% |
| Sep 30, 2024 | -33.48% |
| Jun 30, 2024 | -30.49% |
| Mar 31, 2024 | -18.82% |
| Dec 31, 2023 | -21.36% |
| Sep 30, 2023 | -23.30% |
| Jun 30, 2023 | -29.26% |
| Mar 31, 2023 | -17.54% |
| Dec 31, 2022 | -27.78% |
| Sep 30, 2022 | -17.20% |
| Jun 30, 2022 | -15.33% |
| Mar 31, 2022 | -13.29% |
| Dec 31, 2021 | -13.42% |
| Sep 30, 2021 | -18.05% |
| Jun 30, 2021 | -14.27% |
| Mar 31, 2021 | -10.30% |